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Background: Over the past decade, many trials have suggested that intracoronary stem cell transplantation therapy can improve cardiac function 
after acute myocardial infarction (AMI). However, many clinical studies evaluating the role of intracoronary stem cells in post-AMI patients have 
yielded mixed Results: Hence, a meta-analysis was done to ascertain the influence of intracoronary stem cell transplantation in patients after AMI 
on left ventricular function and volumes.
Methods: A total of 17 randomized trials involving 969 patients (control group, 437 patients; stem cell group, 532 patients) were identified. 
Primary end point analyzed was change in global left ventricular ejection fraction (LVEF) comparing baseline and follow up measurements. Secondary 
end point was change in left ventricular end-diastolic volume (LVEDV). Standard difference in means (SDIM) across all studies and 95% confidence 
intervals (CI) were computed. A two-sided alpha error of less than 0.05 was considered to be statistically significant.
Results: The baseline characteristics were similar in both groups. The intracoronary stem cell transplantation therapy in post-AMI patients 
significantly increased LVEF (SDIM: 0.598, CI: 0.304-0.892; p value <0.001). Also, LVEDV was significantly decreased in patients receiving stem cell 
therapy (SDIM: -0.267, CI: -0.47 to -0.06; p value = 0.01).
Conclusions: Intracoronary stem cell transplantation therapy after AMI significantly improves cardiac function. 
